Biosite Diagnostics


May 14, 07

NEW STORY
21:41 ET Biosite Determines That Revised Binding Offer From Inverness Constitutes a 'Superior Proposal'

 
May 10, 07

16:30 ET Biosite Prepared to Enter Into Discussions With Inverness Medical Innovations

 
07:30 ET Biosite Receives Revised Offer From Inverness Medical Regarding Possible Cash Tender Offer

 
May 02, 07

20:01 ET Biosite Incorporated Reports New Option Grants Under NASDAQ Marketplace Rule 4350

 
02:15 ET Biosite and Beckman Coulter Amend Definitive Merger Agreement

 
Apr 25, 07

23:54 ET Biosite Determines That Offer From Inverness Constitutes a 'Superior Proposal'

 
Apr 24, 07

16:08 ET Biosite Incorporated Announces First Quarter 2007 Results

 
08:30 ET Biosite Announces Regulatory Clearance in Germany of Beckman Coulter Tender Offer

 
Apr 23, 07

07:45 ET Reminder - Biosite to Conduct First Quarter 2007 Results Conference Call

 
Apr 20, 07

08:30 ET Biosite Incorporated Receives Further Revised Commitment Letters From Inverness Medical Regarding Possible Merger Transaction

 
Apr 18, 07

08:30 ET Biosite Incorporated Receives Revised Commitment Letters From Inverness Medical Regarding Possible Merger Transaction

 
Apr 17, 07

11:34 ET Biosite to Conduct First Quarter 2007 Results Conference Call

 
08:30 ET Biosite Announces Expiration of Hart-Scott-Rodino Waiting Period for Tender Offer With Beckman Coulter

 
Apr 10, 07

08:30 ET Biosite Prepared to Enter Into Discussions With Inverness Medical Innovations

 
Apr 05, 07

08:30 ET Biosite Incorporated Receives Unsolicited Letter from Inverness Medical Regarding Possible Cash Merger Transaction

 
Mar 28, 07

06:00 ET Biosite Reports on Presentation of Preliminary Data From Sepsis Program

 
Mar 14, 07

14:12 ET Biosite(R) Incorporated to Webcast Presentation of Early Investigational Data at International Symposium on Intensive Care and Emergency Medicine

 
Mar 05, 07

09:00 ET Biosite Expands Distributor Network in the Physician Office Segment

 
Feb 01, 07

18:40 ET Biosite Incorporated Reports New Option Grants Under Nasdaq Marketplace Rule 4350

 
Jan 30, 07

16:02 ET Biosite Incorporated Announces 2006 Fourth Quarter and Annual Results

 
Jan 29, 07

07:45 ET Reminder - Biosite to Conduct Fourth Quarter and Year End Results Conference Call

 
Jan 05, 07

19:36 ET Biosite to Conduct Fourth Quarter and Year End Results Conference Call

 
Nov 10, 06

14:21 ET Biosite Announces Presentation at the JPMorgan 2006 Small/Mid Cap Conference

 
Nov 01, 06

16:02 ET Biosite Incorporated Reports New Option Grants Under NASDAQ Marketplace Rule 4350

 
Oct 26, 06

16:13 ET Biosite(R) Incorporated Announces Results for the Third Quarter of 2006

 
07:45 ET REMINDER - Biosite to Conduct Third Quarter Results Conference Call

 
Oct 13, 06

11:55 ET Biosite to Conduct Third Quarter Results Conference Call

 
Sep 26, 06

03:00 ET Biosite Moves European Headquarters to Switzerland

 
Sep 20, 06

09:29 ET Biosite Incorporated to Host 3rd Annual Investor R&D Day Conference

 
Sep 01, 06

12:02 ET Biosite Announces Presentation at the Thomas Weisel Partners 2006 Healthcare Conference

 
Aug 23, 06

05:00 ET Biosite and Hopitaux Universitaires de Geneve Announce Kidney Injury Collaboration

 
Aug 15, 06

19:43 ET Biosite(R) Incorporated Reports New Option Grants Under NASDAQ Market Rule 4350

 
Jul 26, 06

16:00 ET Biosite(R) Incorporated Announces Results for the Second Quarter of 2006

 
07:45 ET Reminder - Biosite to Conduct Second Quarter Results Conference Call

 
Jul 24, 06

13:49 ET Biosite(R) Incorporated Introduces Triage(R) MeterPro(TM)

    
Jul 13, 06

07:00 ET Biosite(R) Announces FDA Clearance to Market Triage(R) TOX Drug Screen

 
Jul 07, 06

13:43 ET Biosite to Conduct Second Quarter Results Conference Call

 
Jul 06, 06

07:00 ET Biosite(R) Incorporated Reports New Option Grants Under NASDAQ Marketplace Rule 4350

 
Jun 23, 06

14:35 ET Biosite Announces Presentations at the Inaugural Jeffries Life Sciences Conference and at William Blair & Company's 26th Annual Growth Stock Conference

 
Jun 16, 06

14:00 ET Biosite Announces Presentation at Nasdaq's 17th Annual Investor Program

 
May 17, 06

07:15 ET Reminder - Biosite Announces Presentation at the Third Annual GARP Investor Conference

 
07:00 ET Biosite(R) Incorporated to Withdraw Triage(R) Stroke Panel PMA

 
May 12, 06

14:24 ET Biosite Announces Presentation at the Third Annual GARP Investor Conference

 
Apr 28, 06

16:01 ET Biosite(R) Incorporated Reports New Option Grants Under NASDAQ Market Rule 4350

 
Apr 24, 06

16:02 ET Biosite(R) Incorporated Announces Results for the First Quarter of 2006

 
07:45 ET Reminder: Biosite to Conduct First Quarter Results Conference Call

 
Apr 13, 06

07:30 ET Biosite to Conduct First Quarter Results Conference Call

 
Apr 04, 06

05:00 ET Biosite and Oxford Genome Sciences Announce Collaboration in Colorectal Cancer

 
Feb 21, 06

08:04 ET Biosite and FivePrime Announce Antibody Collaboration

 
Feb 09, 06

16:03 ET Biosite(R) Incorporated Announces 2005 Annual and Fourth Quarter Results

 
07:45 ET Reminder - Biosite to Conduct Fourth Quarter and Year End Results Conference Call

 
Jan 26, 06

11:01 ET Biosite(R) Incorporated Reports New Option Grants Under NASDAQ Market Rule 4350

 
Jan 25, 06

16:06 ET Biosite(R) Incorporated Announces Change in Management

 
Jan 17, 06

14:00 ET Biosite to Conduct Fourth Quarter and Year End Results Conference Call

 
Jan 06, 06

19:36 ET Biosite Announces Presentation at the 24th Annual JP Morgan Healthcare Conference

 
Jan 03, 06

08:02 ET Biosite Announces U.S. 510(k) Filing for MPO Tests

 
Dec 19, 05

08:02 ET Biosite Incorporated and Roche Diagnostics Request Stay of Litigation

 
Nov 15, 05

16:01 ET Biosite(R) Incorporated Announces Presentation at the 2005 Credit Suisse First Boston Healthcare Conference

 
Oct 25, 05

16:07 ET Biosite(R) Incorporated Announces Results for the Third Quarter of 2005

 
16:05 ET Biosite(R) Incorporated and Fisher Healthcare Sign Three-Year Distribution Agreement

 
07:45 ET Reminder - Biosite(R) Incorporated to Conduct 3rd Quarter Results Conference Call

 
Oct 20, 05

16:05 ET Biosite(R) Incorporated Reports New Option Grants Under NASDAQ Market Rule 4350

 
Oct 07, 05

08:01 ET Biosite(R) Incorporated Reports New Stock Option Grants Under Nasdaq Market Rule 4350 and Increase to Share Reserve Under 2002 Nonqualified Stock Incentive Plan

 
08:00 ET Biosite Announces Two New Senior Vice Presidents

 
Oct 05, 05

21:02 ET Biosite(R) Incorporated to Host 2nd Annual Research and Development Conference

 
Oct 04, 05

20:07 ET Biosite(R) Incorporated to Conduct 3rd Quarter Results Conference Call

 
Sep 28, 05

07:01 ET Biosite Gains Additional Claim for Triage(R) BNP Test

 
Sep 23, 05

17:02 ET Biosite(R) Incorporated Announces Presentation at the 2005 UBS Life Science Conference

 
Sep 02, 05

16:39 ET Biosite(R) Incorporated Announces Presentation at the 2005 Thomas Weisel Partners Healthcare Tailwinds Conference

 
Aug 29, 05

07:01 ET Biosite(R) Incorporated Receives CLIA Waiver for Triage(R) BNP Test

    
Aug 25, 05

07:00 ET SIRS-Lab and Biosite(R) Incorporated Announce Collaboration to Develop Diagnostics for Sepsis

 
Aug 22, 05

08:03 ET Biosite(R) Incorporated Announces Exclusive License for Cardiovascular Marker

 
Aug 16, 05

18:00 ET Biosite(R) Incorporated Announces Presentation at the Eighth Annual San Diego Growth Conference

 
Aug 01, 05

08:03 ET Biosite(R) Incorporated Announces Collaboration for Cerebrovascular Injury Targets

 
Jul 26, 05

16:04 ET Biosite(R) Incorporated Announces 29 Percent Increase in 2nd Quarter 2005 Earnings Per Share

 
07:45 ET Reminder - Biosite(R) Incorporated to Conduct 2nd Quarter Results Conference Call

 
Jul 14, 05

11:11 ET Biosite(R) Incorporated to Conduct 2nd Quarter Results Conference Call

 
Jul 13, 05

08:00 ET Biosite(R) Incorporated Announces Exclusive License for Novel Renal Injury Marker

 
Jun 27, 05

08:06 ET Biosite(R) Incorporated Adds Two Vice Presidents to Executive Management

 
Jun 22, 05

08:01 ET Biosite(R) Incorporated Announces Development Strategy for MPO

 
Jun 21, 05

08:01 ET Biosite(R) Incorporated Reports New Option Grants Under NASDAQ Market Rule 4350

 
Jun 17, 05

17:46 ET Biosite(R) Incorporated Announces Presentation at William Blair 25th Annual Growth Stock Conference

 
Jun 10, 05

20:45 ET Biosite(R) Incorporated Announces Participation at Thomas Weisel Partners Growth Forum 7.0

 
May 19, 05

12:01 ET Biosite(R) Incorporated to Conduct Investor Conference Call Following European Stroke Conference Symposium

 
12:00 ET Biosite Incorporated to Webcast Presentation of Clinical Data at European Stroke Conference

 
Apr 21, 05

16:15 ET Biosite(R) Incorporated Announces 38 Percent Increase in Diluted E.P.S. for 1st Quarter of 2005; Raises Guidance

 
07:45 ET Reminder - Biosite(R) Incorporated to Conduct 1st Quarter Results Conference Call

 
Apr 15, 05

17:33 ET Biosite(R) Incorporated Reports New Option Grants Under NASDAQ Market Rule 4350

 
Apr 08, 05

09:00 ET European and U.S. Clinicians to Present at European Stroke Conference

 
Apr 07, 05

14:00 ET Biosite(R) Incorporated to Conduct 1st Quarter Results Conference Call

 
Mar 14, 05

13:57 ET UPDATE: Biosite(R) Incorporated Announces Presentation at SG Cowen & Co. 25th Annual Health Care Conference

 
Mar 11, 05

08:00 ET Biosite(R) Incorporated Announces Presentation at SG Cowen & Co. 25th Annual Health Care Conference

 
Mar 02, 05

08:02 ET Biosite(R) Announces FDA Clearance to Market Triage(R) TOX Drug Screens With Acetaminophen

 
Feb 21, 05

08:00 ET Triage(R) Stroke Panel Premarket Approval Application Accepted for Review by FDA

 
Feb 16, 05

08:01 ET Biosite(R) Incorporated Announces Availability of Triage(R) D-Dimer Test in the United States

 
Feb 07, 05

16:15 ET Biosite(R) Incorporated Announces Presentation at Merrill Lynch Conference

 
07:30 ET Biosite Announces License Agreement for Novel Diagnostic Targets

 
Jan 26, 05

16:07 ET Biosite(R) Reports Strong Fourth Quarter Growth in Sales, Net Income and Operating Margins

 
Jan 24, 05

13:01 ET Biosite(R) Incorporated Announces Presentation at Piper Jaffray Conference

 
Jan 21, 05

12:57 ET Biosite(R) Incorporated to Conduct 4th Quarter Results Conference Call

 
Jan 17, 05

19:30 ET Biosite(R) Incorporated Reports New Option Grants Under NASDAQ Market Rule 4350

 
Jan 04, 05

08:02 ET Biosite(R) Announces U.S. Filing of Its Premarket Approval Application for Triage(R) Stroke Panel

 
Dec 02, 04

11:00 ET Biosite(R) Incorporated Announces FDA Clearance for Triage(R) D-Dimer Test

 
Nov 30, 04

08:01 ET Biosite(R) Incorporated Announces Complaint Filed Against Roche Diagnostics

 
Nov 12, 04

08:02 ET Biosite(R) Incorporated Announces Complaint Filed by Roche Diagnostics

 
Oct 26, 04

16:01 ET Biosite(R) Incorporated Reports Third Quarter 2004 Earnings Per Share Growth of 58 Percent on Revenue Growth of 43 Percent

 
07:46 ET Reminder - Biosite(R) Incorporated to Conduct 3rd Quarter Results Conference Call

 
Oct 22, 04

16:48 ET Biosite(R) Incorporated Reports New Option Grants Under Nasdaq Market Rule 4350

 
13:00 ET Biosite Incorporated Announces Management Promotions

 
Oct 06, 04

17:56 ET Biosite(R) Incorporated's 2004 R&D Conference

 
Oct 05, 04

14:07 ET Biosite(R) Incorporated to Conduct 3rd Quarter Results Conference Call

 
Sep 23, 04

17:08 ET Biosite(R) Incorporated Announces Presentation at Credit Suisse First Boston HOLT Advisor Small and Mid-Cap Forum

 
Sep 16, 04

11:30 ET Biosite(R) Incorporated Names Robin Weiner Vice President, Regulatory and Government Affairs

 
Sep 02, 04

06:00 ET Biosite(R) Incorporated Announces Presentation at Thomas Weisel Partners Conference

 
Aug 26, 04

06:01 ET Biosite(R) Incorporated Reports New Option Grants Under Nasdaq Market Rule 4350

 
Jul 29, 04

16:39 ET Biosite(R) Incorporated Reports Second Quarter 2004 Results and Preliminary Stroke Data

 
16:31 ET /C O R R E C T I O N -- Biosite(R) Incorporated/

 
07:47 ET Reminder - Biosite(R) Incorporated to Conduct 2nd Quarter Results Conference Call

 
Jul 27, 04

06:01 ET Biosite(R) and Henry Schein Sign Distribution Agreement for Physician Office Segment

 
Jul 26, 04

08:31 ET Biosite(R) Incorporated Announces Call for Second Quarter 2004 Financial Results and Business Update

 
Jul 15, 04

16:08 ET Biosite(R) Incorporated to Surpass Expectations for Second Quarter 2004

 
Jul 14, 04

17:00 ET Biosite(R) Incorporated Names Bill Ferenczy Vice President Marketing

 
Jul 02, 04

07:30 ET Biosite(R) Incorporated to Conduct 2nd Quarter Results Conference Call

 
Jul 01, 04

13:26 ET Biosite(R) Incorporated Names Sarah Gunhouse Vice President of U.S. Sales

 
Jun 30, 04

07:30 ET Biosite(R) Incorporated Receives FDA Clearance for New Emergency Department Diagnostic Test

 
Jun 18, 04

16:14 ET Biosite(R) Incorporated Reports New Option Grants Under NASDAQ Market Rule 4350

 
11:00 ET Biosite(R) Incorporated Announces Presentation at William Blair & Company 24th Annual Growth Stock Conference

 
Jun 10, 04

12:48 ET Biosite(R) Incorporated Announces Presentation at Thomas Weisel Partners' Growth Forum 6.0

 
May 20, 04

11:00 ET Biosite(R) Incorporated Announces Presentation at Suntrust Robinson Conference

 
May 14, 04

11:00 ET Biosite(R) Incorporated Announces Presentation at Banc of America Securities Healthcare Conference

 
Apr 28, 04

16:36 ET Biosite(R) Incorporated Raises Annual Guidance on Strong First Quarter Results

 
08:01 ET Reminder - Biosite(R) Incorporated to Conduct 1st Quarter Results Conference Call

 
Apr 07, 04

16:00 ET Biosite(R) Incorporated Raises Sales and Earnings Forecast for First Quarter 2004

 
Apr 01, 04

17:00 ET Biosite(R) Incorporated Reports New Option Grants Under Nasdaq Market Rule 4350

 
12:53 ET Biosite(R) Incorporated to Conduct 1st Quarter Results Conference Call

 
Mar 25, 04

11:00 ET Biosite(R) Incorporated and COLA Provide Additional Online Triage(R) Test Training

 
Mar 04, 04

08:33 ET Biosite(R) Incorporated Signs Discovery Collaboration With DMI BioSciences

 
Feb 25, 04

07:30 ET Biosite Announces License Agreement With The Cleveland Clinic for Cardiovascular Disease Test

 
Feb 12, 04

07:34 ET Biosite Test for Heart Failure Highlighted in New England Journal of Medicine

    
07:34 ET New England Journal of Medicine Highlights BNP as Early Warning Signal For Future Cardiovascular Disease

 
Feb 02, 04

08:31 ET Biosite(R) Signs Discovery Collaboration With Amylin Pharmaceuticals

 
08:06 ET Biosite(R) to Host Analyst Meeting Prior to American Stroke Association's International Stroke Conference

 
Jan 29, 04

11:40 ET Biosite(R) Announces FDA Clearance for New Sample Collection Process for Its Gold Standard Triage(R) BNP Test

 
Jan 26, 04

16:05 ET Biosite(R) Reports New Option Grants Under Nasdaq Market Rule 4350

 
16:02 ET Biosite(R) Incorporated Reports Fourth Quarter 2003 Results

 
07:00 ET Reminder - Biosite(R) Incorporated to Conduct 4th Quarter Results Conference Call

 
Jan 23, 04

08:05 ET Biosite(R) Incorporated Announces Presentation at Piper Jaffray Conference

 
Jan 20, 04

08:31 ET Biosite(R) Incorporated Expands Reach Into Europe

 
Jan 06, 04

17:22 ET Biosite(R) Incorporated to Conduct 4th Quarter Results Conference Call

 
Dec 30, 03

07:30 ET Biosite(R) Receives FDA Clearance For Triage(R) BNP Test for Beckman Coulter Platforms

 
Dec 22, 03

01:30 ET Biosite(R) Incorporated Triage(R) BNP Test Approved for Usage on Beckman Coulter Platforms

 
Nov 26, 03

08:00 ET Agenix and Biosite(R) Incorporated Enter Into License for D-dimer

 
Oct 22, 03

16:18 ET Biosite(R) Incorporated Reports Third Quarter 2003 Results

 
07:45 ET Reminder: Biosite(R) Incorporated to Conduct 3rd Quarter Results Conference Call

 
Oct 07, 03

19:27 ET Biosite(R) Incorporated to Conduct 3rd Quarter Results Conference Call

 
Sep 25, 03

07:45 ET Reminder: Biosite(R) Incorporated to Webcast Conference Call to Discuss Third Quarter Update

 
Sep 24, 03

20:12 ET Webcast Alert: Biosite(R) Incorporated to Webcast Conference Call to Discuss Third Quarter Update

 
16:29 ET Trial Results Demonstrate Testing BNP Levels May Improve Emergency Department Triage Decisions for CHF Patients

 
Sep 23, 03

18:17 ET Biosite(R) Incorporated Revises 2003 Guidance

 
Sep 02, 03

12:51 ET Biosite(R) Incorporated Announces Presentation at Thomas Weisel Healthcare Conference

 
Aug 06, 03

07:30 ET Biosite(R) Incorporated Announces Start of RABBIT Clinical Trial to Evaluate BNP in an Outpatient Setting

 
Aug 01, 03

22:18 ET Biosite(R) Incorporated Announces Presentation At Adams Harkness and Hill Investor Conference

 
Jul 24, 03

16:01 ET Biosite(R) Incorporated Reports Second Quarter 2003 Results

 
Jul 10, 03

07:49 ET Biosite(R) Incorporated to Webcast 2nd Quarter Conference Call

 
Jul 07, 03

16:00 ET Biosite(R) Incorporated and Fisher HealthCare Sign Two-Year Distribution Agreement

 
01:00 ET Biosite(R) Incorporated Announces Launch of Biosite France

 
Jun 25, 03

08:04 ET Biosite(R) and Beckman Coulter Sign BNP Test Agreement

 
Jun 24, 03

20:58 ET Biosite(R) Incorporated to Webcast Conference Call

 
Jun 23, 03

07:01 ET Biosite(R) and COLA Provide Online Triage(R) BNP Test Training

 
Jun 20, 03

07:00 ET Biosite(R) Incorporated Announces Presentation At William Blair Investor Conference

 
Jun 12, 03

14:15 ET Biosite(R) Incorporated Announces Presentation at Thomas Weisel Investor Conference

 
May 15, 03

07:01 ET Rapid, Point-of-Care Congestive Heart Failure Test Soon to Be Available in Physician Office Practices

 
May 13, 03

08:19 ET Triage(R) Cardio ProfilER Now Available in the United States

 
May 02, 03

12:05 ET Biosite(R) Incorporated Updates Replay Information to 1st Quarter Conference Call

 
07:00 ET Biosite(R) Incorporated Announces Presentation at Deutsche Bank Annual Healthcare Conference

 
May 01, 03

16:02 ET Biosite(R) Incorporated Reports First Quarter 2003 Results

 
07:45 ET Reminder - Biosite Incorporated Invites You to Its 1st Quarter Conference Call

 
Apr 14, 03

13:20 ET Biosite Incorporated Invites You to Its 1st Quarter Conference Call

 
Mar 24, 03

18:41 ET Biosite(R) Incorporated Announces Presentation At Banc of America Securities Healthcare Conference

 
Mar 06, 03

07:00 ET Biosite(R) Receives FDA Clearance for New Chest Pain Screen

 
Feb 20, 03

10:15 ET Biosite(R) Announces Collaboration Agreement With Neurocrine Biosciences

 
Feb 10, 03

16:42 ET Ciphergen and Biosite Announce Collaboration

 
Jan 27, 03

16:07 ET Biosite(R) Incorporated Reports Fourth Quarter 2002 Revenue and EPS Growth

 
Jan 08, 03

17:29 ET Biosite(R) Incorporated to Webcast 4th Quarter Conference Call

 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2007 PR Newswire Association LLC. ALL Rights Reserved.
A United Business Media company.